| Sterile protection against human malaria by chemoattenuated PfSPZ vaccine B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ... Nature 542 (7642), 445-449, 2017 | 357 | 2017 |
| Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness AR Falsey, JE McElhaney, J Beran, GA Van Essen, X Duval, M Esen, ... The Journal of infectious diseases 209 (12), 1873-1881, 2014 | 215 | 2014 |
| Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies MF Muellenbeck, B Ueberheide, B Amulic, A Epp, D Fenyo, CE Busse, ... Journal of Experimental Medicine 210 (2), 389-399, 2013 | 208 | 2013 |
| The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1 D Krappmann, E Wegener, Y Sunami, M Esen, A Thiel, B Mordmuller, ... Molecular and cellular biology 24 (14), 6488-6500, 2004 | 177 | 2004 |
| Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism B Mordmüller, D Krappmann, M Esen, E Wegener, C Scheidereit EMBO reports 4 (1), 82-87, 2003 | 177 | 2003 |
| Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells M Esen, B Schreiner, V Jendrossek, F Lang, K Fassbender, H Grassme, ... Apoptosis 6, 431-439, 2001 | 174 | 2001 |
| AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial JE McElhaney, J Beran, JM Devaster, M Esen, O Launay, G Leroux-Roels, ... The Lancet infectious diseases 13 (6), 485-496, 2013 | 165 | 2013 |
| Safety and immunogenicity of GMZ2—a MSP3–GLURP fusion protein malaria vaccine candidate M Esen, PG Kremsner, R Schleucher, M Gässler, EB Imoukhuede, ... Vaccine 27 (49), 6862-6868, 2009 | 142 | 2009 |
| Natural infection of Plasmodium brasilianum in humans: man and monkey share quartan malaria parasites in the Venezuelan Amazon A Lalremruata, M Magris, S Vivas-Martínez, M Koehler, M Esen, ... EBioMedicine 2 (9), 1186-1192, 2015 | 140 | 2015 |
| Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres B Mordmüller, C Supan, KL Sim, GP Gómez-Pérez, CL Ospina Salazar, ... Malaria journal 14, 1-11, 2015 | 118 | 2015 |
| Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older AL Cunningham, TC Heineman, H Lal, O Godeaux, R Chlibek, SJ Hwang, ... The Journal of infectious diseases 217 (11), 1750-1760, 2018 | 115 | 2018 |
| First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria B Mordmüller, M Sulyok, D Egger-Adam, M Resende, WA de Jongh, ... Clinical Infectious Diseases 69 (9), 1509-1516, 2019 | 109 | 2019 |
| Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized … D Kieninger, E Sheldon, WY Lin, CJ Yu, JM Bayas, JJ Gabor, M Esen, ... BMC infectious diseases 13, 1-13, 2013 | 109 | 2013 |
| A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children SB Sirima, B Mordmüller, P Milligan, UA Ngoa, F Kironde, F Atuguba, ... Vaccine 34 (38), 4536-4542, 2016 | 104 | 2016 |
| Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70 E Böttger, G Multhoff, JFJ Kun, M Esen PLoS One 7 (3), e33774, 2012 | 101 | 2012 |
| Invasion of Human Epithelial Cells byPseudomonas aeruginosa Involves Src-Like Tyrosine Kinases p60Src and p59Fyn M Esen, H Grassmé, J Riethmüller, A Riehle, K Fassbender, E Gulbins Infection and immunity 69 (1), 281-287, 2001 | 99 | 2001 |
| Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial N Wressnigg, EM Pöllabauer, G Aichinger, D Portsmouth, A Löw-Baselli, ... The Lancet infectious diseases 13 (8), 680-689, 2013 | 95 | 2013 |
| Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon B Mordmüller, K Szywon, B Greutelaers, M Esen, L Mewono, C Treut, ... Vaccine 28 (41), 6698-6703, 2010 | 91 | 2010 |
| A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children S Belard, S Issifou, AB Hounkpatin, F Schaumburg, UA Ngoa, M Esen, ... PloS one 6 (7), e22525, 2011 | 89 | 2011 |
| A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children S Belard, S Issifou, AB Hounkpatin, F Schaumburg, UA Ngoa, M Esen, ... PloS one 6 (7), e22525, 2011 | 89 | 2011 |
